反応 #71434
ord-8d8046c7e3954c319573c523e794f7b2
反応方程式
反応物
試薬
溶媒
反応条件
後処理
- 1その他quenched by addition of MeOH
- 2濃縮concentrated
- 3workup.DISSOLUTIONThe residue was dissolved in MeOH (5 mL)
- 4温度heated
- 5温度to reflux for 3 h
- 6温度to cool
- 7ろ過The resulting solid was collected by filtration
- 8workup.ADDITIONdiluted in in DCM
- 9抽出a saturated aqueous solution of NaHCO3, and extracted with DCM
- 10乾燥The organic phase was dried (Na2SO4)
- 11ろ過filtered
- 12濃縮concentrated
- 13その他The residue was purified by silica gel column chromatography (DCM/MeOH/NH3aq, 91.5:7.5:1)
実験手順
α-Chloroethyl chloroformate (19 μL, 0.17 mmol) was added to a cold (−78° C.) solution of 8-(3,5-dimethoxy-phenyl)-quinoxaline-5-carboxylic acid {5-[4-(4-methoxy-benzyl)-piperazin-1-ylmethyl]pyridin-2-yl}-amide (Example 116) (103 mg, 0.17 mmol) in THF (2 mL). The reaction mixture was stirred for 1 h at −78° C., quenched by addition of MeOH and concentrated. The residue was dissolved in MeOH (5 mL), heated to reflux for 3 h, allowed to cool. The resulting solid was collected by filtration, diluted in in DCM and a saturated aqueous solution of NaHCO3, and extracted with DCM. The organic phase was dried (Na2SO4), filtered and concentrated. The residue was purified by silica gel column chromatography (DCM/MeOH/NH3aq, 91.5:7.5:1) followed by trituration in Et2O to afford 28 mg of the title compound as a white solid. Title compound: ESI-MS: 485.2 [M+H]+; tR=3.80 min (System 1); TLC: Rf=0.10 (DCM/MeOH/NH3aq, 91.5:7.5:1).